Edwards Lifesciences Corp. (EW)
90.76
+0.56
(+0.62%)
USD |
NYSE |
Aug 31, 16:00
90.76
0.00 (0.00%)
After-Hours: 20:00
Edwards Lifesciences Cash from Operations (Annual) : 1.595B for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 1.595B |
| December 31, 2024 | 542.30M |
| December 31, 2023 | 895.80M |
| December 31, 2022 | 1.218B |
| December 31, 2021 | 1.732B |
| December 31, 2020 | 1.054B |
| December 31, 2019 | 1.179B |
| December 31, 2018 | 926.80M |
| December 31, 2017 | 1.001B |
| December 31, 2016 | 704.40M |
| December 31, 2015 | 549.70M |
| December 31, 2014 | 1.022B |
| December 31, 2013 | 472.70M |
| December 31, 2012 | 373.80M |
| December 31, 2011 | 314.50M |
| Date | Value |
|---|---|
| December 31, 2010 | 251.40M |
| December 31, 2009 | 165.30M |
| December 31, 2008 | 153.20M |
| December 31, 2007 | 210.20M |
| December 31, 2006 | 230.80M |
| December 31, 2005 | 136.80M |
| December 31, 2004 | 180.60M |
| December 31, 2003 | 122.30M |
| December 31, 2002 | 120.60M |
| December 31, 2001 | 101.00M |
| December 31, 2000 | 137.00M |
| December 31, 1999 | |
| December 31, 1998 | 176.00M |
| December 31, 1997 | 163.00M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Stryker Corp. | 5.044B |
| Intuitive Surgical, Inc. | 3.030B |
| Abbott Laboratories | 9.566B |
| Zimmer Biomet Holdings, Inc. | 1.697B |
| Solventum Corp. | 369.00M |